Literature DB >> 4905

Irreversible protein binding of norethisterone (norethindrone) epoxide.

H Kappus, H M Bolt.   

Abstract

14,15-3H-Norethisterone-4 beta, 5 beta-epoxide, a metabolite of norethisterone, was incubated with several proteins and nucleic acids. After 30 min incubation 0.19 nmol of the epoxide were irreversibly bound per mg albumin which contains free sulfhydryl groups; proteins without SH-groups, such as concanavalin A, gamma-globulin, DNA and RNA, did not irreversibly bind norethisterone epoxide. A superoxide (O2) generating enzyme system comprised of xanthine oxidase and hypoxanthine was capable of catalyzing the irreversible binding of the parent compound, norethisterone, to albumin, indicating that an oxidation product was formed which reacted with the protein. When norethisterone epoxide was incubated for 60 min with hepatic microsomes of rats in absence of NADPH, about 2.0 nmol of the epoxide were irreversibly incorporated per mg microsomal protein. This binding was increased to 5.2 nmol by addition of a NADPH regenerating system. Addition of glutathione and cytosol decreased only the NADPH-dependent protein binding; phenobarbital pretreatment of rats induced this NADPH-dependent binding of norethisterone epoxide to microsomal protein by a factor of 2. In presence of NADPH, binding of the epoxide to microsomal protein depended on substrate concentration used. The results indicate that norethisterone epoxide is able to chemically react with proteins. In addition, hepatic microsomal enzymes convert the epoxide to another metabolite which also can react with proteins.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 4905     DOI: 10.1016/0039-128x(76)90067-2

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  7 in total

1.  Covalent binding of drug metabolites to DNA--a tool of predictive value?

Authors:  H M Bolt; R J Laib
Journal:  Arch Toxicol       Date:  1980-11       Impact factor: 5.153

2.  Self-catalyzed destruction of cytochrome P-450: covalent binding of ethynyl sterols to prosthetic heme.

Authors:  P R Ortiz de Montellano; K L Kunze; G S Yost; B A Mico
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

3.  Structural modifications in contraceptive steroids altering their metabolism and toxicity.

Authors:  H M Bolt
Journal:  Arch Toxicol       Date:  1977-12-30       Impact factor: 5.153

4.  The photochemical decomposition of the progestogenic 19-norsteroid, norethisterone, in aqueous medium.

Authors:  A G Sedee; G M Beijersbergen van Henegouwen; H De Vries; W Guijt; C A Haasnoot
Journal:  Pharm Weekbl Sci       Date:  1985-10-25

5.  Mutagenicity and chromosomal aberrations as an analytical tool for in vitro detection of mammalian enzyme-mediated formation of reactive metabolites.

Authors:  H Greim; D Bimboes; G Egert; W Göggelmann; M Krämer
Journal:  Arch Toxicol       Date:  1977-12-30       Impact factor: 5.153

6.  Interaction of estrone and estradiol with DNA and protein of liver and kidney in rat and hamster in vivo and in vitro.

Authors:  M Caviezel; W K Lutz; U Minini; C Schlatter
Journal:  Arch Toxicol       Date:  1984-07       Impact factor: 5.153

7.  Irreversible Binding of Norethisterone to Human Serum Protein Induced by UV-B Light.

Authors:  A Sedee; G B van Henegouwen; K Lusthof; G Lodder
Journal:  Pharm Res       Date:  1984-05       Impact factor: 4.200

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.